SIGMAR1 and HIV-1 infection: We also hypothesized that treatment with Sig1R antagonist BD1047 prior to cocaine will obliterate HIV-1 infection in macrophages, decrease CATB levels and its related neurodegenerative effects in vitro and in vivo.